Qing-he Xing

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Liver transcriptome sequencing contributes to the molecular diagnosis of genetic liver diseases.

Liver transcriptome sequencing contributes to the molecular diagnosis of genetic liver diseases.

Journal: Hepatology (Baltimore, Md.)
Published: October 11, 2025

A novel mechanism involving USP53-regulated BSEP trafficking underlies low-GGT intrahepatic cholestasis.

A novel mechanism involving USP53-regulated BSEP trafficking underlies low-GGT intrahepatic cholestasis.

Journal: Hepatology (Baltimore, Md.)
Published: June 05, 2025

The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.

The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.

Journal: Innovation (Cambridge (Mass.))
Published: July 11, 2024

Splicing Analysis of MYO5B Noncanonical Variants in Patients with Low Gamma-Glutamyltransferase Cholestasis.

Splicing Analysis of MYO5B Noncanonical Variants in Patients with Low Gamma-Glutamyltransferase Cholestasis.

Journal: Human mutation
Published: April 24, 2023

Transcript selection for the genetic diagnosis of KIF12-associated progressive familial intrahepatic cholestasis.

Transcript selection for the genetic diagnosis of KIF12-associated progressive familial intrahepatic cholestasis.

Journal: Gastroenterology report
Published: March 28, 2023

Recurrent AKR1D1 c.580-13T>A Variant: A Cause of Δ4-3-Oxosteroid-5β-Reductase Deficiency.

Recurrent AKR1D1 c.580-13T>A Variant: A Cause of Δ4-3-Oxosteroid-5β-Reductase Deficiency.

Journal: The Journal of molecular diagnostics : JMD
Published: July 28, 2022

Association of novel TMEM67 variants with mild phenotypes of high gamma-glutamyl transpeptidase cholestasis and congenital hepatic fibrosis.

Association of novel TMEM67 variants with mild phenotypes of high gamma-glutamyl transpeptidase cholestasis and congenital hepatic fibrosis.

Journal: Journal of cellular physiology
Published: November 16, 2021

MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.

MYO5B-associated diseases: Novel liver-related variants and genotype-phenotype correlation.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 24, 2021

Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis.

Biallelic loss-of-function ZFYVE19 mutations are associated with congenital hepatic fibrosis, sclerosing cholangiopathy and high-GGT cholestasis.

Journal: Journal of medical genetics
Published: November 17, 2019

TJP2 hepatobiliary disorders: Novel variants and clinical diversity.

TJP2 hepatobiliary disorders: Novel variants and clinical diversity.

Journal: Human mutation
Published: August 10, 2019

HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.

HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.

Journal: Basic & clinical pharmacology & toxicology
Published: December 20, 2017

Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.

Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.

Journal: Hepatology (Baltimore, Md.)
Published: April 13, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026